This article refers to:
Qiu L, Cui Q, Gong X, Zhou H. J Asthma Allergy. 2023;16:195-200.
The authors have advised that the manufacturer for iodixanol on page 196, Case Report section, second paragraph, line 3, should be changed from Visipaque 320, GE Healthcare, Cork, Ireland to Jiangsu Hengrui Medicine Co., Ltd
The sentence should read from
“For this procedure, the patient received a total of 70 mL of iodixanol intravenously (Visipaque 320, GE Healthcare, Cork, Ireland).”
to
“For this procedure, the patient received a total of 70 mL of iodixanol intravenously (Jiangsu Hengrui Medicine Co., Ltd).”
The authors apologize for this error.